Lupus & antiphospholipid syndrome

Macrophage colony-stimulating factor receptor/CD115 + non-classical monocytes are expanded in systemic lupus erythematosus and associated with lupus nephritis

Scand J RheumatolPublished Cross-sectional study

Authors' conclusion

The non-classical monocyte subset in SLE is characterized by an expansion of M-CSF receptor/CD115+ cells that are associated with lupus nephritis and coexpress slan.

Study context

Population
Patients with systemic lupus erythematosus (SLE), healthy age-matched controls and patients with autoimmune connective tissue disease other than SLE
Participants
39 / 32 / 16
Exposure
SLE vs healthy age-matched controls vs disease controls
  • SLEn = 39
  • Healthy controlsn = 32reference
  • Disease controln = 16
Outcome
Phenotype of non-classical monocytes (CD115, CD116, slan) by flow cytometry
Methodological detailsflow cytometry, chart review
  • Flow cytometry
  • Chart review

Main finding

As reported in the abstract

  • Non-classical monocytes showed a cell-type specific signature of high macrophage colony-stimulating factor (M-CSF) receptor CD115 and low granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor CD116 expression, separating them from the other two monocyte subsets
  • In healthy individuals, CD115 on non-classical monocytes was age-dependent, with lower expression in young adults
  • SLE: marked expansion of CD115+ non-classical monocytes in patients of all ages
  • Expanded CD115+ non-classical monocytes associated with LN but not with disease activity, and coexpressed slan

Observational data: associations, not effects.

Original publication

Macrophage colony-stimulating factor receptor/CD115 + non-classical monocytes are expanded in systemic lupus erythematosus and associated with lupus nephritis. Scand J Rheumatol. Published 22 August 2024. doi:10.1080/03009742.2024.2387483

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.